Alloplastic skin substitute (SUPRATHEL®) dressings in treatment of donor sites in children with burns Aim of research: The aim of this study was to investigate the efficiency of alloplastic skin substitute dressings on pain syndrome and epitheliazation of donor sites in burned children. Materials and Methods: Twenty-four patients with 2-3 degree burns up 3% to 15% of body surface were studied. Patients were treated in Burn Center from 1 January to 31 December 2016. Split grafts were isolated with disc dermatome. Thickness of grafts was 0.3-0.4 mm. SUPRATHEL® was placed on donor wounds in 11 patients. In control group (13 patients) one-level gauze ointment dressings were used. Patients age in SUPRATELR and control group did not differ (11.9±3.36 and 14.2±4.94 months, Z=-1.2, p=0.23). Results: In SUPRATHEL® group the dressings were not removed until complete epitheliazation of donor wounds and changing of SUPRATHEL® dressings was not necessary. In control group changing of dressings was needed in 4 patients. The Study has proved that in case of use of alloplastic skin substitute SUPRATHEL®, median epitheliazation time was 5.7±1.01 days, in control group - time was 8.7±1.49 days (Z=-3.8, p=0.0002). According to Verbal Descriptor Scale expression of pain syndrome was less in SUPRATHEL® group than in control group (1.5±1.04 and 5.2±0.9 respectively, Z=-4.1, P<0.001). Conclusion: Our study shown that use of alloplastic skin substitute SUPRATHEL® is effective in treatment of donor wounds in pediatric burns. Time of epithelization is shortened and pain syndrome is reduced.
No datasets are available for this submission.
No license information is available for this submission.